CANCER TREATMENT REVIEWS, 0305-7372
Journal
Related Publications
Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities
de Vries, G., Rosas-Plaza, X., van Vugt, M. A. T. M., Gietema, J. A. & de Jong, S., 1-Aug-2020, In : CANCER TREATMENT REVIEWS. 88, 12 p., 102054.Research output: Contribution to journal › Review article › Academic › peer-review
Reconsider radiation exposure from imaging during immune checkpoint inhibitor trials to reduce risk of secondary cancers in long-term survivors?
Knapen, D. G., de Groot, D. J. A., Kwee, T. C., Meijne, E. I. M., Fehrmann, R. S. N. & de Vries, E. G. E., Jul-2020, In : CANCER TREATMENT REVIEWS. 87, 4 p., 102027.Research output: Contribution to journal › Review article › Academic › peer-review
Current management of stage IV nasopharyngeal carcinoma without distant metastasis
Ng, W. T., Corry, J., Langendijk, J. A., Lee, A. W. M., Mäkitie, A., Mendenhall, W. M., Rinaldo, A., Rodrigo, J. P., Saba, N. F., Smee, R., Strojan, P., Suárez, C., Vermorken, J. B. & Ferlito, A., Apr-2020, In : CANCER TREATMENT REVIEWS. 85, 10 p., 101995.Research output: Contribution to journal › Review article › Academic › peer-review
Primary and acquired resistance mechanisms to immune checkpoint inhibition in Hodgkin lymphoma
Veldman, J., Visser, L., Berg, A. V. D. & Diepstra, A., Jan-2020, In : CANCER TREATMENT REVIEWS. 82, 9 p., 101931.Research output: Contribution to journal › Review article › Academic › peer-review
Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer - ESMO-MCBS scores
Broekman, K. E., Jalving, M., van Tinteren, H., Sessa, C. & Reyners, A. K. L., Sep-2018, In : CANCER TREATMENT REVIEWS. 69, p. 233-242 10 p.Research output: Contribution to journal › Review article › Academic › peer-review
ID: 2006534